Urocortin II (The Salk Institute for Biological Studies)

尿皮质激素II

Report date: 2022/02/21 11:09:21

Base Information

Drug NameUrocortin II (The Salk Institute for Biological Studies)
Drug Alias Nameurocortin II
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCorticotropin-releasing factor receptor 2 stimulants
TargetsCorticotropin-releasing factor receptor 2
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSalk Institute for Biological Studies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurocrine Biosciences IncSalk Institute for Biological Studies
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A